Hypertension: all 6,834 studies

Page 68 of 69. Open to participants first (971), then studies with results posted, then the rest; newest registration first within each.

• Clevidipine in the Postoperative Treatment of Hypertension (ECLIPSE-NIC)CompletedNCT00093925Phase 3
• Clevidipine in the Perioperative Treatment of Hypertension (ECLISPE-SNP)CompletedNCT00093912Phase 3
• Clevidipine in the Perioperative Treatment of Hypertension (ECLIPSE-NTG)CompletedNCT00093886Phase 3
• Study of Clevidipine Assessing Its Postoperative Antihypertensive Effect in Cardiac Surgery (ESCAPE-2)CompletedNCT00093262Phase 3
• Study of Clevidipine Assessing Its Preoperative Antihypertensive Effect in Cardiac Surgery (ESCAPE-1)CompletedNCT00093249Phase 3
• Antihypertensive Efficacy and Safety of Approved Drugs in Japanese Patients With Essential Hypertension (Banyu Study)(0954A-302)CompletedNCT00092209Phase 3
• Efficacy and Safety of Oral Bosentan in Pulmonary Arterial Hypertension Class IICompletedNCT00091715Phase 3
• ARIES - Ambrisentan in Patients With Moderate to Severe Pulmonary Arterial Hypertension (PAH)CompletedNCT00091598Phase 3
• Genetic and Environmental Characteristics of Primary Pulmonary HypertensionCompletedNCT00091546
• Biochemical and Genetic Markers of Hypertension in WomenCompletedNCT00090467
• Systolic Pressure Efficacy and Safety Trial of Alagebrium (SPECTRA)TerminatedNCT00089713Phase 2
• Trial of Iloprost Inhaled Solution as Add-On Therapy With Bosentan in Subjects With Pulmonary Arterial Hypertension (PAH)CompletedNCT00086463Phase 2
• HYPGENE-Genetics Fitness Obesity & Risk of HypertensionCompletedNCT00083811
• The Effect of Tracleer® on Male FertilityCompletedNCT00082186Phase 4
• Safety and Efficacy Study of Sitaxentan Sodium (Thelin™) in Patients With Pulmonary Arterial HypertensionCompletedNCT00080457Phase 3
• Natrecor in Pulmonary HypertensionTerminatedNCT00075179Phase 4
• Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension PatientsCompletedNCT00069719Phase 2
• Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-angle Glaucoma or Ocular Hypertension PatientsCompletedNCT00069706Phase 2
• Hypertension in HemodialysisCompletedNCT00067665Not applicable
• Women's Use of Alternative Medicine: A Multiethnic StudyCompletedNCT00067249
• Genes of Hypertension in African AmericansCompletedNCT00063505
• Angiotensinogen Gene and Human HypertensionCompletedNCT00063492
• Safety and Efficacy Study of BETOPTIC S 0.25% and Timolol Gel-forming Solution 0.25% and 0.5% in Pediatric Patients With Glaucoma or Ocular HypertensionCompletedNCT00061542Phase 3
• A Phase III Study of Brimonidine Tartrate Ophthalmic Solution, 0.15% in Patients With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00061529Phase 3
• Safety and Efficacy Study of BETAXON 0.5% and AZOPT 1.0% in Pediatric Patients With Glaucoma or Ocular HypertensionCompletedNCT00061516Phase 3
• Mechanism of Action of TRAVATAN 0.004% in Subjects With Glaucoma or Ocular HypertensionCompletedNCT00061503Phase 4
• Effect Of Carvedilol Versus Metoprolol On Glycemic Control In Patients With Type II Diabetes And HypertensionCompletedNCT00060931Phase 4
• Glycemic Control Of Carvedilol Versus Metoprolol In Patients With Type II Diabetes Mellitus And HypertensionCompletedNCT00060918Phase 4
• Secondary Prevention of Small Subcortical Strokes TrialCompletedNCT00059306Phase 3
• A Transition Study From Flolan® to Remodulin® in Patients With Pulmonary Arterial HypertensionCompletedNCT00058929Phase 4
• A 6-week Safety & Efficacy Study of Combination Intraocular Pressure-lowering Therapy in Patients With Open-angle Glaucoma or Ocular HypertensionCompletedNCT00051194Phase 2
• A 6-Week Safety and Efficacy Study of Travatan Compared to Xalcom in Subjects With Open-Angle Glaucoma(OAG) or Ocular Hypertension(OHT)CompletedNCT00051155Phase 3
• A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT)CompletedNCT00051142Phase 3
• Phase 4 Study Comparing IOP Lowering in OAG or OH in Caucasian or Japanese Subjects C-02-32TerminatedNCT00047606Phase 4
• Phase 3 Study Comparing IOP Lowering in OAG or OH in Japanese Subjects C-01-98CompletedNCT00047593Phase 3
• Study of TRAVATAN in Subjects With Iris Pigmentation ChangesTerminatedNCT00047554
• Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-01-70CompletedNCT00047541Phase 3
• Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-02-41CompletedNCT00047528Phase 3
• Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-01-69CompletedNCT00047515Phase 3
• Study of BSF 208075 Evaluating Exercise Capacity in Patients With Pulmonary Arterial HypertensionCompletedNCT00046319Phase 2
• The SILVER Study: Systolic Hypertension Interaction With Left Ventricular RemodelingCompletedNCT00045994Phase 2
• The SAPPHIRE Study (Systolic And Pulse Pressure Hemodynamic Improvement By Restoring Elasticity)CompletedNCT00045981Phase 2
• Treatment of Pediatric Hypertension With Altace TrialCompletedNCT00044265Phase 4
• Telmisartan vs. Valsartan in Patients With Mild to Moderate Hypertension Following a Missed DoseCompletedNCT00034840Phase 4
• Safety and Efficacy of Sitaxsentan in the Treatment of Pulmonary Arterial HypertensionStatus unknownNCT00034307Phase 2/3
• Hypertension: Prediction of Biofeedback SuccessCompletedNCT00026065Phase 1
• Nitric Oxide and Transfusion Therapy for Sickle Cell Patients With Pulmonary HypertensionCompletedNCT00023296Phase 1
• Treatment Effects on Platelet Calcium in Hypertensive and Depressed PatientsCompletedNCT00018759Phase 4
• Insulin Action: Role of Skeletal Muscle and Insulin-Mediated Blood FlowCompletedNCT00018304
• Inhaled Nitric Oxide for Preterm Infants With Severe Respiratory FailureTerminatedNCT00016523Phase 3
• Guidelines for Drug Therapy of Hypertension: Closing the LoopCompletedNCT00012636Not applicable
• Improving Service Delivery Through Access PointsCompletedNCT00012623
• Dose-Response to Exercise in Women Aged 45-75 Years (DREW)CompletedNCT00011193
• Acupuncture and HypertensionCompletedNCT00010478Not applicable
• Hypertension Screening and Treatment ProgramCompletedNCT00007592
• Genetics of Hypertension and Its Intermediate PhenotypesCompletedNCT00006499
• Hypertension in Black Americans: A Life Course ApproachCompletedNCT00006408
• Prevention of Esophageal Varices by Beta-Adrenergic BlockersCompletedNCT00006398Phase 3
• Genetics of Hypertension Associated Treatments (GenHAT)CompletedNCT00006294
• Magnetic Resonance Imaging for Evaluating Kidney FunctionCompletedNCT00006173
• Effects of Rosiglitazone on Blood Vessels in Patients With High Blood Pressure and High CholesterolCompletedNCT00006071
• Inhaled Nitric Oxide Study for Respiratory Failure in NewbornsTerminatedNCT00005776Phase 3
• Early Inhaled Nitric Oxide for Respiratory Failure in NewbornsTerminatedNCT00005773Phase 3
• Stress Reduction and Prevention of Hypertension in BlacksCompletedNCT00005748
• Improving Adherence to Interventions for HypertensionCompletedNCT00005708
• Improving Hypertension Care for Inner City MinoritiesCompletedNCT00005707
• Urban African-American Community Hypertension ControlCompletedNCT00005706
• Improving Hypertension Control in the Inner CityCompletedNCT00005699
• IN CONTROL--Hypertension Reduction in Inner City SeattleCompletedNCT00005698
• Blood Pressure Control--Racial and Psychosocial InfluencesCompletedNCT00005685
• Genetic Epidemiology of Responses to AntihypertensivesCompletedNCT00005520
• Multi-Ethnic Study of Atherosclerosis (MESA)Active, not recruitingNCT00005487
• The Jackson Heart Study of Cardiovascular Disease Among African AmericansActive, not recruitingNCT00005485
• Job Strain, Ambulatory Blood Pressure and HypertensionCompletedNCT00005472
• Divergence of Blood Pressure By Race in Adolescent GirlsCompletedNCT00005470
• Maturational Changes in Cardiac Structures -- Blood Pressure Relationship -- SCOR in HypertensionCompletedNCT00005469
• Hypertensive and Normal Pregnancy--Calcium Metabolism and Renin-Angiotensin - SCOR in HypertensionCompletedNCT00005456
• Hypertension in Families of African OriginCompletedNCT00005444
• Opioid Compromise in Hypertension--Modulating FactorsCompletedNCT00005434
• Familial Aggregation of Stress ResponseCompletedNCT00005428
• Physical Activity, Hypertension, Diabetes, and Coronary Heart DiseaseCompletedNCT00005419
• Diagnosis/Pathophysiology of Glucocorticoid Remediable Aldosteronism HypertensionCompletedNCT00005394
• Genetics of Hypertension in BlacksCompletedNCT00005387
• Molecular Epidemiology of Essential HypertensionCompletedNCT00005377
• Pulmonary Hypertension--Mechanisms and Family RegistryCompletedNCT00005357
• Hypertension in Blacks of West African OriginCompletedNCT00005340
• Epidemic Hypertension in Nigerian WorkersCompletedNCT00005333
• Identifying Genes Involved in Abnormal Blood Pressure - Hypertension SCORCompletedNCT00005325
• White Coat Hypertension and Antihypertensive Treatment Effect - SCOR in HypertensionCompletedNCT00005316
• Psychosocial Factors and Cardiovascular DiseaseCompletedNCT00005315
• Hypertension in Minorities Database-Workshop and PublicationCompletedNCT00005311
• Sleep Heart Health Study (SHHS) Data Coordinating CenterCompletedNCT00005275
• Family Blood Pressure Program - SAPPHIRe NetworkCompletedNCT00005270
• Urinary Kallikrein and Hypertension: A Prospective StudyCompletedNCT00005261
• Epidemiology of Hypertensive EmergencyCompletedNCT00005240
• Antecedents of Hypertension: Role of Race and StressCompletedNCT00005238
• Regulation of Placental Vascular Reactivity in Pregnancy-induced HypertensionCompletedNCT00005208
• End-organ Pathology in Childhood Essential HypertensionCompletedNCT00005180
• Socioeconomic Status, John Henryism and Hypertension Risk in BlacksCompletedNCT00005172
• Sodium Transport: Genetics and HypertensionCompletedNCT00005166

← Hypertension overview